BOOKS BY CATEGORY
Your Account
The End of the Beginning
Cancer, Immunity, and the Future of a Cure
This book is currently unavailable – please contact us for further information.
Price
Quantity
€24.40
(To see other currencies, click on price)
Hardback
Add to basket  

MORE ABOUT THIS BOOK

Main description:

For the first time since a 5th century Greek physician gave the name "cancer" (karkinos, in Greek) to a deadly disease first described in Egyptian Papyri, the medical world is near a breakthrough that could allow even the most conservative doctors and pragmatic patients to use the other "c word" - cure - in the same sentence as cancer. A remarkable series of events has brought us to this point, thanks in large part to a new ability to more efficiently harness the extraordinary power of the human immune.

The End of the Beginning is a remarkable history of cancer treatment and the evolution of our understanding of its dynamic interplay with the immune system. Through Michael Kinch's personal experience as a cancer researcher at Washington University and the head of the oncology programme at a leading biotechnology company, we witness the incredible accumulation of breakthrough science and its rapid translation into life-saving technologies that have begun to dramatically increase the quality and quantity of life for cancer patients.

Expanding upon Kinch's own remarkable projects to encompass the vaccines being deployed to eliminate cervical cancer, the development of cancer-specific "smart bombs" in the form of monoclonal antibodies, cellular therapies and checkpoint inhibitors-The End of the Beginning reveals the incredible transformation of cancer treatment happening today. Kinch details the remarkable history of people, science, technology and disease and presents thrilling next-generation technologies that hold the promise to eliminate cancer for some, and perhaps ultimately, for all.


PRODUCT DETAILS

ISBN-13: 9781643130255
Publisher: Pegasus Books
Publication date: April, 2019
Pages: 320
Weight: 480g
Availability: Not available (reason unspecified)
Subcategories: General Issues, Immunology, Oncology

CUSTOMER REVIEWS

Average Rating